Basic Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Oct 14, 2016; 22(38): 8497-8508
Published online Oct 14, 2016. doi: 10.3748/wjg.v22.i38.8497
Table 1 Effect of dietary ethanol or/and guanidinoacetate ingestion on pathology
ControlControl + GAAEthanolEthanol + GAA
Body weight (gm)366.71 ± 20.26a345.93 ± 12.30a301.00 ± 12.49b323.90 ± 12.89a
Liver weight (gm)9.82 ± 0.44a9.47 ± 0.44a11.70 ± 0.36b15.05 ± 0.71c
Liver-to body ratio (%)2.67 ± 0.07a2.74 ± 0.10a3.88 ± 0.25b4.64 ± 0.06c
Serum ALT (U/L)54.43 ± 1.65a56.57 ± 3.96a120.00 ± 15.59b222.00 ± 50.52b
Serum AST (U/L)63.00 ± 3.95a68.40 ± 10.79a135.23 ± 13.86b252.60 ± 54.19b
Serum GAA (μmol/L)1.92 ± 0.31a60.60 ± 6.73b2.97 ± 1.05a23.63 ± 1.32c
Serum ethanol levels (mmol/L)0 ± 0.00a0 ± 0.00a51.10 ± 4.346b44.94 ± 6.28b
Hepatic GAMT activity247.58 ± 22.31a412.13 ± 24.92c207.19 ± 22.32b445.198 ± 23.19c
(pmol Creatine synthesized/min/mg protein)
Kidney AGAT activity10.03 ± 1.17a2.30 ± 0.177b10.39 ± 1.07a2.882 ± 0.44b
(nmol GAA synthesized/min/mg protein)